FDA approves Tymlos for osteoporosis

FDA approved an NDA from Radius Health Inc. (NASDAQ:RDUS) for Tymlos abaloparatide-SC (BA058-SC, ITM-058) to treat postmenopausal women with osteoporosis at high risk for fracture. The company expects to launch the drug in May...